Search results for: Oncology
Filter search results
New OHE Research Paper: Extrapolation from Progression Free Survival to Overall Survival in Oncology
28 December 2016
…Oncology. The Office of Health Economics, in a research project funded by the Pharmaceutical Oncology Initiative (POI), has published a new report entitled: Extrapolation from Progression Free Survival to Overall…
Progression-free Survival as a Surrogate Outcome for Overall Survival in Oncology
4 September 2018
When should progression-free survival be used as a surrogate for overall survival in oncology? A recent article in the International Journal of Technology Assessment in Health Care, co-authored by OHE…
Extrapolation from Progression-Free Survival to Overall Survival in Oncology
1 December 2016
This Research Paper reports on a literature review of trials using PFS as a surrogate for OS in oncology between 2012 and 2016; a workshop and interviews involving people from…
Spotlight on OHE: Value Footprint of Oncology Treatments, Treating Obstructive Sleep Apnoea and Sources of Motivation in Health Care Organisations
4 August 2015
The blog provides links to slide sets and posters relating to the value footprint of oncology treatments, treating obstructive sleep apnoea and sources of motivation in health care organisations. Speaking…
Advances in Oncology Modelling: Recent Results from POI Research
18 September 2012
OHE and the Pharmaceutical Oncology Initiative (POI) held a workshop to discuss and debate several key issues in oncology modelling. Participating were more than 50 experts from industry, academia and…
Innovation in Oncology: Real Option Value and Path Dependence
29 April 2014
Real Option Value and Path Dependence in Oncology Innovation. Based on an OHE Lunchtime Seminar, this Seminar Briefing addresses a persistent issue: how to adequately reward innovation through the pricing…
Real Option Value and Path Dependence in Oncology Innovation
1 April 2014
…at launch. As the author points out, oncology drugs in particular often follow the… Based on an OHE Lunchtime Seminar, this publication addresses a persistent issue: how to adequately reward…
OHE Workshop: Surrogate Endpoints as Predictors of Overall Survival in Oncology
14 July 2016
On Tuesday 28th June 2016 OHE held a workshop on the topic of surrogate endpoints as predictors of overall survival in oncology. The workshop was commissioned by the Pharmaceutical Oncology…
Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology
1 February 2021
…A., Lothgren, M., Steuten, L., and Bruce, A., 2021. Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. OHE Consulting Report, London: Office of Health…